Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

113.69 +2.78 (+2.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,347,263
Open 111.17
Bid (Size) 112.97 (1)
Ask (Size) 113.68 (2)
Prev. Close 110.91
Today's Range 110.03 - 113.83
52wk Range 74.75 - 142.00
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
2 Top Growth Stocks to Buy With $1,000
These stocks have excellent track records of beating the market. 
Via The Motley Fool

Performance

YTD
-7.64%
-7.64%
1 Month
-3.72%
-3.72%
3 Month
-18.17%
-18.17%
6 Month
-8.30%
-8.30%
1 Year
-10.97%
-10.97%

More News

Read More
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
Via InvestorPlace
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Via InvestorPlace
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
The 3 Best Diabetes Stocks to Buy in June 2024
Via InvestorPlace
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
Via Benzinga
In-Depth Examination Of 6 Analyst Recommendations For DexCom
Via Benzinga
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Via Chartmill
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Via Investor's Business Daily
Exposures Product Safety
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Via Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
From Tandem Diabetes Care, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.